• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症患者的心血管疾病风险:一项基于人群的队列研究。

The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study.

机构信息

Section of Rheumatology, Boston University School of Medicine, Boston, MA 02118, USA.

出版信息

Ann Rheum Dis. 2013 Jul;72(7):1188-93. doi: 10.1136/annrheumdis-2012-202007. Epub 2012 Aug 17.

DOI:10.1136/annrheumdis-2012-202007
PMID:22904260
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4386728/
Abstract

OBJECTIVES

To evaluate the risk of incident myocardial infarction (MI), stroke and peripheral vascular disease (PVD) in individuals with systemic sclerosis (SSc) in a general population context.

METHODS

We conducted a cohort study using a UK primary care database containing records from 1986 to 2011. SSc diagnoses, outcomes and cardiovascular risk factors were identified from electronic medical records. We conducted two cohort analyses: (1) MI and stroke, and (2) PVD, excluding individuals with prevalent disease at baseline for each analysis. We estimated HRs comparing SSc with age-, sex- and entry time-matched comparison cohorts, adjusting for potential cardiovascular risk factors.

RESULTS

Among 865 individuals with SSc (85.8% women, mean age 58.7 years), the incidence rates (IRs) of MI and stroke were 4.4 and 4.8 per 1000 person-years (PY), versus 2.5 and 2.5 per 1000 PY in the comparison cohort. The corresponding adjusted HRs were 1.80 (95% CI 1.07 to 3.05) for MI and 2.61 (95% CI 1.54 to 4.44) for stroke. Among 858 individuals with SSc (85.3% female, mean age 58.9 years), the IR of PVD was 7.6 per 1000 PY versus 1.9 per 1000 PY in the comparison cohort, with an adjusted HR of 4.35 (95% CI 2.74 to 6.93).

CONCLUSIONS

These findings provide the first general population-based evidence that SSc is associated with an increased risk of developing MI, stroke and PVD. Further insight into disease mechanisms, as well as how disease subtype, organ involvement and medication use may alter these increased risks, is needed.

摘要

目的

在一般人群背景下,评估系统性硬化症(SSc)个体发生心肌梗死(MI)、中风和外周血管疾病(PVD)的风险。

方法

我们进行了一项队列研究,使用包含 1986 年至 2011 年记录的英国初级保健数据库。从电子病历中确定 SSc 诊断、结局和心血管危险因素。我们进行了两项队列分析:(1)MI 和中风;(2)PVD,在每种分析中均排除基线时存在既往疾病的个体。我们比较了 SSc 与年龄、性别和进入时间匹配的比较队列,调整了潜在的心血管危险因素,估计了 HR。

结果

在 865 名 SSc 患者(85.8%为女性,平均年龄 58.7 岁)中,MI 和中风的发生率(IRs)分别为每 1000 人年 4.4 和 4.8 例,而在比较队列中分别为每 1000 人年 2.5 和 2.5 例。相应的调整后 HR 分别为 MI 1.80(95%CI 1.07 至 3.05)和中风 2.61(95%CI 1.54 至 4.44)。在 858 名 SSc 患者(85.3%为女性,平均年龄 58.9 岁)中,PVD 的 IR 为每 1000 人年 7.6 例,而在比较队列中为每 1000 人年 1.9 例,调整后 HR 为 4.35(95%CI 2.74 至 6.93)。

结论

这些发现提供了首个基于一般人群的证据,表明 SSc 与发生 MI、中风和 PVD 的风险增加有关。需要进一步深入了解疾病机制,以及疾病亚型、器官受累和药物使用如何改变这些增加的风险。

相似文献

1
The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study.系统性硬化症患者的心血管疾病风险:一项基于人群的队列研究。
Ann Rheum Dis. 2013 Jul;72(7):1188-93. doi: 10.1136/annrheumdis-2012-202007. Epub 2012 Aug 17.
2
Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study.巨细胞动脉炎诊断后早期和晚期的心血管疾病风险:一项队列研究。
Ann Intern Med. 2014 Jan 21;160(2):73-80. doi: 10.7326/M12-3046.
3
Association between systemic sclerosis and risk of cerebrovascular and cardiovascular disease: a meta-analysis.系统性硬化症与脑血管和心血管疾病风险的关联:荟萃分析。
Sci Rep. 2024 Mar 18;14(1):6445. doi: 10.1038/s41598-024-57275-9.
4
Risk of bleeding events among patients with systemic sclerosis and the general population in the UK: a large population-based cohort study.英国系统性硬化症患者与普通人群出血事件风险:一项基于人群的大型队列研究。
Clin Rheumatol. 2020 Jan;39(1):19-26. doi: 10.1007/s10067-019-04588-0. Epub 2019 May 14.
5
Early Cardiovascular Disease After the Diagnosis of Systemic Sclerosis.系统性硬化症诊断后的早期心血管疾病
Am J Med. 2016 Mar;129(3):324-31. doi: 10.1016/j.amjmed.2015.10.037. Epub 2015 Nov 19.
6
Hidradenitis suppurativa and the risk of myocardial infarction, cerebrovascular accident, and peripheral vascular disease: a population-based study.化脓性汗腺炎与心肌梗死、脑血管意外和外周血管疾病风险:一项基于人群的研究。
Arch Dermatol Res. 2023 Apr;315(3):429-435. doi: 10.1007/s00403-022-02369-5. Epub 2022 Jul 23.
7
Cardiovascular Manifestations of Systemic Sclerosis: A Danish Nationwide Cohort Study.系统性硬化症的心血管表现:一项丹麦全国队列研究。
J Am Heart Assoc. 2019 Sep 3;8(17):e013405. doi: 10.1161/JAHA.119.013405. Epub 2019 Aug 24.
8
The cardiovascular risk in bullous pemphigoid: Insights from a population-based study.大疱性类天疱疮的心血管风险:一项基于人群的研究的见解。
Australas J Dermatol. 2024 Nov;65(7):e187-e193. doi: 10.1111/ajd.14355. Epub 2024 Aug 1.
9
Contemporary epidemiology of systemic sclerosis: A population-based cohort study in the United Kingdom.当代系统性硬化症的流行病学:英国基于人群的队列研究。
Semin Arthritis Rheum. 2019 Aug;49(1):105-111. doi: 10.1016/j.semarthrit.2018.11.002. Epub 2018 Nov 10.
10
Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study.新诊断系统性红斑狼疮患者心肌梗死和中风的风险:一项基于人群的研究
Arthritis Care Res (Hoboken). 2017 Jun;69(6):849-856. doi: 10.1002/acr.23018. Epub 2017 May 9.

引用本文的文献

1
Cerebrovascular accidents - Unexpected complication of systemic sclerosis: A scarce case report.脑血管意外——系统性硬化症的意外并发症:一例罕见病例报告
Medicine (Baltimore). 2025 Sep 5;104(36):e44331. doi: 10.1097/MD.0000000000044331.
2
Identifying common genes and immune infiltration characteristics between systemic sclerosis and atherosclerosis.识别系统性硬化症和动脉粥样硬化之间的共同基因和免疫浸润特征。
Clin Rheumatol. 2025 Jun 20. doi: 10.1007/s10067-025-07479-9.
3
Increased risk of acute myocardial infarction in Swedish patients with systemic sclerosis: a population-based study.瑞典系统性硬化症患者急性心肌梗死风险增加:一项基于人群的研究。
Rheumatol Adv Pract. 2025 May 9;9(2):rkaf054. doi: 10.1093/rap/rkaf054. eCollection 2025.
4
Aberrant lipid profiles and lymphocyte counts in systemic sclerosis population, reassessing predictive value for concurrent cardiovascular diseases.系统性硬化症患者异常的血脂谱和淋巴细胞计数,重新评估并发心血管疾病的预测价值。
Front Immunol. 2025 Feb 19;16:1530909. doi: 10.3389/fimmu.2025.1530909. eCollection 2025.
5
Long-term cardiovascular outcomes after percutaneous coronary intervention in patients with systemic sclerosis.系统性硬化症患者经皮冠状动脉介入治疗后的长期心血管结局
Int J Cardiol Heart Vasc. 2025 Feb 4;57:101625. doi: 10.1016/j.ijcha.2025.101625. eCollection 2025 Apr.
6
Residual Traditional Risk in Non-Traditional Atherosclerotic Diseases.非传统动脉粥样硬化疾病中的残余传统风险。
Int J Mol Sci. 2025 Jan 10;26(2):535. doi: 10.3390/ijms26020535.
7
Anti-OJ Antibody-positive Antisynthetase Myopathy Diagnosed after Pulmonary Embolization.肺栓塞后诊断的抗OJ抗体阳性抗合成酶肌病
Intern Med. 2025 Jun 1;64(11):1750-1755. doi: 10.2169/internalmedicine.4201-24. Epub 2024 Nov 8.
8
Managing Cardiovascular Risk in Patients with Autoimmune Diseases: Insights from a Nutritional Perspective.管理自身免疫性疾病患者的心血管风险:营养视角的见解。
Curr Nutr Rep. 2024 Dec;13(4):718-728. doi: 10.1007/s13668-024-00563-7. Epub 2024 Jul 30.
9
Association between systemic sclerosis and risk of cerebrovascular and cardiovascular disease: a meta-analysis.系统性硬化症与脑血管和心血管疾病风险的关联:荟萃分析。
Sci Rep. 2024 Mar 18;14(1):6445. doi: 10.1038/s41598-024-57275-9.
10
Systemic sclerosis is associated with increased in-patient mortality in patients hospitalized for heart failure.系统性硬皮病与心力衰竭住院患者的住院死亡率增加有关。
ESC Heart Fail. 2024 Aug;11(4):1900-1910. doi: 10.1002/ehf2.14457. Epub 2024 Mar 12.

本文引用的文献

1
Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis.系统性硬化症全国横断面队列研究中心血管疾病及心血管危险因素的患病率。
Ann Rheum Dis. 2012 Dec;71(12):1980-3. doi: 10.1136/annrheumdis-2011-201176. Epub 2012 Apr 24.
2
UK stroke incidence, mortality and cardiovascular risk management 1999-2008: time-trend analysis from the General Practice Research Database.1999-2008 年英国卒中发病率、死亡率和心血管风险管理:来自普通实践研究数据库的时间趋势分析。
BMJ Open. 2011 Jan 1;1(2):e000269. doi: 10.1136/bmjopen-2011-000269.
3
Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies.系统性硬皮病患者 40 多年来死亡率趋势:队列研究的系统评价和荟萃分析。
Rheumatology (Oxford). 2012 Jun;51(6):1017-26. doi: 10.1093/rheumatology/ker269. Epub 2011 Sep 7.
4
Cardiovascular disease in systemic sclerosis--an emerging association?系统性硬皮病中的心血管疾病——一种新出现的关联?
Arthritis Res Ther. 2011 Aug 26;13(4):237. doi: 10.1186/ar3445.
5
Systemic sclerosis is an independent risk factor for increased coronary artery calcium deposition.系统性硬化症是冠状动脉钙沉积增加的独立危险因素。
Arthritis Rheum. 2011 May;63(5):1387-95. doi: 10.1002/art.30283.
6
The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases.行政数据诊断系统性自身免疫性风湿病的准确性。
J Rheumatol. 2011 Aug;38(8):1612-6. doi: 10.3899/jrheum.101149. Epub 2011 May 1.
7
Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis.系统性硬化症中的动脉粥样硬化:一项系统评价和荟萃分析。
Arthritis Rheum. 2011 Jul;63(7):2078-90. doi: 10.1002/art.30380.
8
Validity of The Health Improvement Network (THIN) for the study of psoriasis.健康改进网络(THIN)在研究银屑病中的有效性。
Br J Dermatol. 2011 Mar;164(3):602-9. doi: 10.1111/j.1365-2133.2010.10134.x. Epub 2011 Feb 3.
9
The burden and measurement of cardiovascular disease in SSc.硬皮病中心血管疾病的负担和评估。
Nat Rev Rheumatol. 2010 Jul;6(7):430-4. doi: 10.1038/nrrheum.2010.65. Epub 2010 Jun 1.
10
Heritability of vasculopathy, autoimmune disease, and fibrosis in systemic sclerosis: a population-based study.系统性硬化症中血管病变、自身免疫性疾病和纤维化的遗传力:一项基于人群的研究。
Arthritis Rheum. 2010 Jul;62(7):2109-16. doi: 10.1002/art.27469.